Protein Therapy

Thymosin β4 Reverses Early Alzheimer’s Defects in Organoids and Mouse Models

Published in Stem Cell Reports, researchers demonstrate thymosin β4 supplementation corrects amyloid buildup in preclinical Alzheimer’s models